EVs from docetaxel-resistant prostate cancer cells were capable of transferring resistance to recipient cells, potentially due to EV Multidrug resistance-1 (MDR-1)/P-glycoprotein (P-gp) transfer preventing accumulation of drugs within cells through active drug efflux [9]. This evidence concerns the gene ABCB1 and prostate carcinoma.